Marshall Wace North America’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $9.48M | Sell |
|
|||||
|
2021
Q2 | $16.6M | Sell |
|
|||||
|
2021
Q1 | $34.6M | Sell |
|
|||||
|
2020
Q4 | $62.4M | Buy |
|
|||||
|
2020
Q3 | $25.8M | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $272K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $23.4M | Buy |
|
|||||
|
2019
Q2 | $23.1M | Sell |
|
|||||
|
2019
Q1 | $86M | Buy |
|
|||||
|
2018
Q4 | $46.6M | Sell |
|
|||||
|
2018
Q3 | $69.1M | Sell |
|
|||||
|
2018
Q2 | $82.6M | Sell |
|
|||||
|
2018
Q1 | $102M | Sell |
|
|||||
|
2017
Q4 | $105M | Buy |
|
|||||
|
2017
Q3 | $3.53M | Sell |
|
|||||
|
2017
Q2 | $27.4M | Sell |
|
|||||
|
2017
Q1 | $35.5M | Buy |
|